Clinical characteristics of gastrointestinal lymphomas associated with AIDS (GI-ARL) and the impact of HAART

HIV Clinical Trials
Sridhar SrinivasanAsher Chanan-Khan

Abstract

The gastrointestinal (GI) tract is the most common site of extranodal disease in patients with systemic non-Hodgkin's lymphoma (NHL). Patients with systemic NHL and GI involvement associated with AIDS (GI-ARL) have a significantly worse prognosis than those without AIDS. We studied whether the introduction of HAART is associated with improved survival in patients with GI-ARL. 36 patients with GI-ARL were identified from the tumor registries of a large municipal hospital in New York City and a tertiary care facility in western New York State. Of these, 28 patients did not receive HAART and 8 were treated with HAART. The primary endpoint was survival, which was defined as time from date of diagnosis of NHL until death from any cause. Patients were analyzed based on whether or not they were treated with HAART. Kaplan-Meier analysis showed significantly better survival in patients with GI-ARL who were concurrently treated with HAART (p =.014). Median survival was 5 months for the no-HAART group and 30 months for the HAART group. In patients with GI-ARL who were treated with chemotherapy, concurrent therapy with HAART therapy was associated with improved survival.

References

Sep 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P S GillS Rasheed
Nov 1, 1989·British Journal of Cancer·R OtterR Willemze
Jul 1, 1995·Mayo Clinic Proceedings·C Y WangW P Su
Apr 1, 1993·Scandinavian Journal of Gastroenterology·F ParenteG Bianchi Porro
Sep 18, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B HolkovaA Chanan-Khan
Sep 18, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P KochUNKNOWN German Multicenter Study Group
Jan 12, 2002·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·David J Straus
Apr 12, 2002·International Journal of Cancer. Journal International Du Cancer·Henry K TamRoger Detels
Aug 3, 2002·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Laurence GérardEric Oksenhendler
Nov 28, 2002·International Journal of Cancer. Journal International Du Cancer·M P CarrieriDiego Serraino
Jan 15, 2003·Annual Review of Medicine·David T Scadden
Feb 8, 2003·The Lancet Oncology·Luigino Dal Maso, Silvia Franceschi

❮ Previous
Next ❯

Citations

Jul 25, 2008·Clinical Lymphoma & Myeloma·Swati AndhavarapuGeetha R Nair

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.